Loading clinical trials...
Loading clinical trials...
A Randomized, Controlled, Double-Masked, Multicenter Trial Designed to Evaluate Acute Tear Production With the Oculeve Intranasal Lacrimal Stimulator Compared to Two Control Applications in Patients With Aqueous Deficient Dry Eye
Conditions
Interventions
Oculeve Intranasal
Sham
+1 more
Locations
2
United States
The Eye Care Group
Waterbury, Connecticut, United States
Virginia Eye Consultants
Norfolk, Virginia, United States
Start Date
January 31, 2016
Primary Completion Date
March 31, 2016
Completion Date
March 31, 2016
Last Updated
April 26, 2019
NCT07295691
NCT03135327
NCT06771427
NCT06220474
NCT06291194
NCT04685109
Lead Sponsor
Oculeve, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions